DRTS (Alpha Tau Medical) OCF Margin %: 0.00% (As of Mar. 2026)


DRTS Alpha Tau Medical Ltd DRTS
28 GF Score
Price $13.22
! 3 Warning Signs
View Full Analysis

What is Alpha Tau Medical OCF Margin %?

Alpha Tau Medical DRTS +4.67% 28 OCF Margin % is 0.00% as of Mar. 2026. GuruFocus rates DRTS with a GF Score™ of 28/100. The stock has 3 warning signs investors should review. Among 951 Biotechnology companies, Alpha Tau Medical ranks worse than 105152.37% on this metric.

OCF Margin % is calculated as Cash Flow from Operations divided by its Revenue. Alpha Tau Medical's Cash Flow from Operations for the three months ended in Mar. 2026 was $0.00 Mil. Alpha Tau Medical's Revenue for the three months ended in Mar. 2026 was $0.00 Mil. Therefore, Alpha Tau Medical's OCF Margin % for the quarter that ended in Mar. 2026 was 0.00%.

As of today, Alpha Tau Medical's current OCF Yield % is -2.23%.

The historical rank and industry rank for Alpha Tau Medical's OCF Margin % or its related term are showing as below:


DRTS's OCF Margin % is not ranked *
in the Biotechnology industry.
Industry Median: -64.23
* Ranked among companies with meaningful OCF Margin % only.

Alpha Tau Medical OCF Margin % Related Terms

Alpha Tau Medical OCF Margin % Historical Data

* Premium members only.

The historical data trend for Alpha Tau Medical's OCF Margin % can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alpha Tau Medical OCF Margin % Chart

Alpha Tau Medical Annual Data
Trend Dec19 Dec20 Dec21 Dec22 Dec23 Dec24 Dec25
OCF Margin %
Get a 7-Day Free Trial 0.00 0.00 0.00 0.00 0.00

Alpha Tau Medical Quarterly Data
Jun21 Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26
OCF Margin % Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only 0.00 0.00 0.00 0.00 0.00
DRTS
28GF Score
Alpha Tau Medical Ltd DRTS
OCF Margin % is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alpha Tau Medical OCF Margin % Calculation

OCF Margin % is the ratio of Cash Flow from Operations divided by net sales or Revenue, usually presented in percent.

Alpha Tau Medical's OCF Margin for the fiscal year that ended in Dec. 2025 is calculated as

OCF Margin=Cash Flow from Operations (A: Dec. 2025 )/Revenue (A: Dec. 2025 )
=-26.681/0
= %

Alpha Tau Medical's OCF Margin for the quarter that ended in Mar. 2026 is calculated as

OCF Margin=Cash Flow from Operations (Q: Mar. 2026 )/Revenue (Q: Mar. 2026 )
=0/0
= %

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Frequently Asked Questions Learn more about OCF Margin % →
What does a OCF Margin % of 0.00% mean?
Alpha Tau Medical (DRTS) has a OCF Margin % of 0.00% as of Mar. 2026. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Alpha Tau Medical and its competitors. According to the industry distribution chart, Alpha Tau Medical ranks #999999 out of 951 companies in the Biotechnology industry.
Is Alpha Tau Medical's OCF Margin % too high?
Alpha Tau Medical's current OCF Margin % is 0.00%. Based on the distribution chart, Alpha Tau Medical ranks #999999 out of 951 companies in the Biotechnology industry, which is in the bottom quartile relative to peers. Overall, Alpha Tau Medical has a GF Score™ of 28/100, reflecting its overall financial health beyond just this single metric.
How does Alpha Tau Medical's OCF Margin % compare to ORIC and OLMA?
According to the Biotechnology industry distribution chart, Alpha Tau Medical ranks #999999 out of 951 companies for OCF Margin %. This places Alpha Tau Medical in the lower half of its industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good OCF Margin % for a Biotechnology company?
A good OCF Margin % depends on the Biotechnology industry context. However, OCF Margin % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high OCF Margin % mean?
A high OCF Margin % can signal that a stock is expensive relative to its fundamentals. OCF Margin is the ratio of Cash Flow from Operations to Total Revenue. View historical data on Alpha Tau Medical and its competitors. Alpha Tau Medical's current OCF Margin % is 0.00%. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alpha Tau Medical stock overvalued right now?
Alpha Tau Medical (DRTS) has a current OCF Margin % of 0.00%. The current OCF Margin % is 0.00%. Alpha Tau Medical's overall GF Score™ is 28/100 with 3 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is OCF Margin % calculated?
OCF Margin % is calculated from a company's financial statements. For Alpha Tau Medical (DRTS), the current OCF Margin % is 0.00% as of Mar. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Alpha Tau Medical Business Description

Address Kiryat HaMada Street 5, Jerusalem, ISR, 9777605
Alpha Tau Medical Ltd is a clinical-stage oncology therapeutics company focused on harnessing the innate relative biological effectiveness and short range of alpha particles for use as a localized radiation therapy for solid tumors. Its proprietary Alpha DaRT technology is designed to utilize the specific therapeutic properties of alpha particles while aiming to overcome, and even harness for potential benefit, the traditional shortcomings of alpha radiation's limited range. The company has active clinical programs targeting a range of different tumor types, such as head and neck cancer, pancreatic cancer, brain cancer, liver metastases, lung cancer, and prostate cancer. Geographically, it operates in Israel, United States, and Japan with the majority of the revenue generated from Israel.
28GF Score

Get the complete analysis for DRTS

OCF Margin % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

$13.22
Price